Parallel Advisors’s CryoPort CYRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.85K Hold
118
﹤0.01% 3535
2026
Q1
$977 Buy
118
+17
+17% +$154 ﹤0.01% 3546
2025
Q4
$970 Hold
101
﹤0.01% 3301
2025
Q3
$957 Hold
101
﹤0.01% 3231
2025
Q2
$753 Hold
101
﹤0.01% 3249
2025
Q1
$614 Buy
+101
New +$699 ﹤0.01% 3209
2023
Q4
Sell
-4,699
Closed -$64.4K 3357
2023
Q3
$64.4K Hold
4,699
﹤0.01% 1272
2023
Q2
$81.1K Sell
4,699
-118
-2% -$2.41K ﹤0.01% 1169
2023
Q1
$116K Hold
4,817
﹤0.01% 992
2022
Q4
$83.6K Hold
4,817
﹤0.01% 1059
2022
Q3
$117K Hold
4,817
0.01% 896
2022
Q2
$149K Buy
4,817
+2,179
+83% +$58K 0.01% 802
2022
Q1
$92K Sell
2,638
-25
-0.9% -$945 ﹤0.01% 1023
2021
Q4
$158K Buy
+2,663
New +$184K 0.01% 835

Other funds holding CYRX

Parallel Advisors's CYRX Position: Q2 2026 in Review

Parallel Advisors held its CryoPort (CYRX) position steady in Q2 2026 at 118 shares worth $1.85K. The position accounts for ﹤0.01% of the portfolio, ranked #3535.

Parallel Advisors first reported a position in CYRX in Q4 2021 and has held it in 14 quarters since. The position peaked at $158K in Q4 2021. 184 funds tracked by Wall St. Rank hold CYRX as of Q2 2026.

  • Parallel Advisors held 118 shares of CryoPort worth $1.85K as of Q2 2026.
  • Parallel Advisors left its CryoPort share count unchanged in Q2 2026.
  • CryoPort made up ﹤0.01% of Parallel Advisors's portfolio in Q2 2026, its #3535 holding.
  • Parallel Advisors first reported a position in CryoPort in Q4 2021 and has held it in 14 quarters since.
  • Parallel Advisors's CryoPort position peaked at $158K in Q4 2021.
  • 184 funds tracked by Wall St. Rank held CryoPort as of Q2 2026.

Based on Parallel Advisors's 13F filing for Q2 2026, filed 5 Aug 2026.